Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 10, 2014 | Director | 5,200 | $94.42 | Sell | $490,984.00 | |
| Sept. 5, 2014 | Director | 2,500 | $94.75 | Sell | $236,875.00 | |
| Sept. 3, 2014 | Director | 5,200 | $92.79 | Sell | $482,508.00 | |
| Aug. 27, 2014 | Director | 5,200 | $93.31 | Sell | $485,212.00 | |
| Aug. 20, 2014 | Director | 5,200 | $91.51 | Sell | $475,852.00 | |
| Aug. 13, 2014 | Director | 5,200 | $88.00 | Sell | $457,600.00 | |
| Aug. 6, 2014 | Director | 5,200 | $86.54 | Sell | $450,008.00 | |
| July 31, 2014 | Director | 5,000 | $89.59 | Sell | $447,950.00 | |
| July 31, 2014 | SVP | 2,027 | $88.97 | Sell | $180,342.19 | |
| July 30, 2014 | Director | 5,200 | $92.17 | Sell | $479,284.00 | |
| July 15, 2014 | Director | 4,800 | $96.65 | Sell | $463,920.00 | |
| July 1, 2014 | Director | 5,000 | $95.21 | Sell | $476,050.00 | |
| July 1, 2014 | EVP | 30,134 | $95.22 | Sell | $2,869,359.48 | |
| June 24, 2014 | SVP | 12,734 | $98.03 | Sell | $1,248,314.02 | |
| June 24, 2014 | Director | 15,000 | $98.03 | Sell | $1,470,450.00 | |
| June 16, 2014 | EVP | 7,500 | $68.31 | Sell | $512,325.00 | |
| June 9, 2014 | Director | 2,500 | $75.00 | Sell | $187,500.00 | |
| May 14, 2014 | EVP | 7,500 | $67.45 | Sell | $505,875.00 | |
| May 2, 2014 | SVP | 1,000 | $67.62 | Sell | $67,620.00 | |
| April 15, 2014 | EVP | 7,500 | $61.63 | Sell | $462,225.00 | |
| April 9, 2014 | Director | 2,500 | $70.00 | Sell | $175,000.00 | |
| March 21, 2014 | Director | 8,700 | $74.59 | Sell | $648,933.00 | |
| March 17, 2014 | EVP | 7,500 | $78.29 | Sell | $587,175.00 | |
| Feb. 7, 2014 | CEO | 35,944 | $80.00 | Sell | $2,875,520.00 | |
| Jan. 22, 2014 | Director | 8,300 | $84.47 | Sell | $701,101.00 | |
| Jan. 21, 2014 | SVP | 1,250 | $85.00 | Sell | $106,250.00 | |
| Jan. 16, 2014 | CEO | 45,000 | $80.00 | Sell | $3,600,000.00 | |
| Jan. 15, 2014 | EVP | 7,500 | $78.67 | Sell | $590,025.00 | |
| Dec. 23, 2013 | Director | 8,300 | $73.02 | Sell | $606,066.00 | |
| Dec. 16, 2013 | EVP | 7,500 | $64.69 | Sell | $485,175.00 | |
| Dec. 12, 2013 | SVP | 5,083 | $65.48 | Sell | $332,834.84 | |
| Dec. 12, 2013 | EVP | 4,532 | $65.46 | Sell | $296,664.72 | |
| Dec. 12, 2013 | CEO | 9,834 | $65.48 | Sell | $643,930.32 | |
| Dec. 4, 2013 | Director | 1,400 | $67.48 | Sell | $94,472.00 | |
| Nov. 25, 2013 | Director | 1,400 | $66.89 | Sell | $93,646.00 | |
| Nov. 20, 2013 | Director | 8,300 | $65.28 | Sell | $541,824.00 | |
| Nov. 19, 2013 | Director | 1,400 | $62.31 | Sell | $87,234.00 | |
| Nov. 5, 2013 | Director | 1,400 | $65.64 | Sell | $91,896.00 | |
| Oct. 29, 2013 | SVP | 1,688 | $75.04 | Sell | $126,667.52 | |
| Oct. 29, 2013 | Director | 1,400 | $75.42 | Sell | $105,588.00 | |
| Oct. 24, 2013 | Director | 8,300 | $77.06 | Sell | $639,598.00 | |
| Oct. 23, 2013 | Director | 1,400 | $76.77 | Sell | $107,478.00 | |
| Oct. 16, 2013 | Director | 1,400 | $75.41 | Sell | $105,574.00 | |
| Oct. 15, 2013 | EVP | 7,500 | $73.25 | Sell | $549,375.00 | |
| Oct. 14, 2013 | SVP | 1,593 | $71.87 | Sell | $114,488.91 | |
| Oct. 9, 2013 | Director | 1,400 | $72.35 | Sell | $101,290.00 | |
| Sept. 25, 2013 | Director | 1,400 | $74.72 | Sell | $104,608.00 | |
| Sept. 18, 2013 | Director | 1,400 | $77.43 | Sell | $108,402.00 | |
| Sept. 16, 2013 | EVP | 7,500 | $77.22 | Sell | $579,150.00 | |
| Sept. 11, 2013 | Director | 1,400 | $79.61 | Sell | $111,454.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.